20
Participants
Start Date
October 19, 2017
Primary Completion Date
January 31, 2023
Study Completion Date
January 31, 2025
clarithromycin, lenalidomide, dexamethasone and autologous BCMA-directed CAR T-cells
"* clarithromycin: 500mg, PO, twice daily, on days 1\~21 for a 28-day cycle.~* lenalidomide: 25mg, PO, on days 1\~21 for a 28-day cycle. dexamethasone: 40mg, PO on days 1,8,15 and 22 for a 28-day cycle. BCMA CAR T cell: (2-3)×10E7/kg, intravenously infusion.~* Doses should be adjusted according to renal function."
RECRUITING
The First Affiliated Hospital of Soochow University, Suzhou
Collaborators (1)
Changshu Frist People's Hospital
UNKNOWN
The Second People's Hospital of Huai'an
OTHER
Affiliated Hospital of Jiangnan University
OTHER
Jiangsu Province Hospital of Traditional Chinese Medicine
OTHER
Jiangyin People's Hospital
OTHER
Jingjiang People's Hospital
OTHER
The Third People's Hospital of Kunshan
UNKNOWN
Lianyungang Hospital Affiliated Bengbu Medical College
OTHER
Suzhou Municipal Hospital
OTHER
Zhangjiagang First People's Hospital
OTHER
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
INDUSTRY
The First Affiliated Hospital with Nanjing Medical University
OTHER
Nanjing Medical University
OTHER
The First Affiliated Hospital of Soochow University
OTHER